|
|
|
|
A more recent version of this article appeared on October 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 28, 2005
Revised on July 21, 2005
Accepted on July 25, 2005
Department of Cell Biology, School of Medicine, University of Virginia Health System, Charlottesville, VA 22908
Monitoring Editor: Jean Schwarzbauer
ADAM (A Disintegrin and A Metalloprotease) family members have been implicated in many biological processes. While it is recognized that recombinant ADAM disintegrin domains can interact with integrins, little is known about ADAM-integrin interactions in cellular context. Here we tested whether ADAMs can selectively regulate integrin-mediated cell migration. ADAMs were expressed in chinese hamster ovary (CHO) cells that express defined integrins (
4
1,
5
1, or both), and cell migration on full-length fibronectin or on its
4
1 or
5
1 binding fragments was studied. We found that ADAMs inhibit integrin-mediated cell migration in patterns dictated by the integrin binding profiles of their isolated disintegrin domains. ADAM12 inhibited cell migration mediated by the
4
1, but not the
5
1, integrin. ADAM17 had the reciprocal effect; it inhibited
5
1, but not
4
1-mediated cell migration. ADAM19 and ADAM33 inhibited migration mediated by both
4
1 and
5
1 integrins. A point mutation in the ADAM12 disintegrin loop partially reduced the inhibitory effect of ADAM12 on cell migration on the
4
1 binding fragment of fibronectin, while mutations that block metalloprotease activity had no effect. Our results indicate that distinct ADAMs can modulate cell migration mediated by specific integrins in a pattern dictated, at least in part, by their disintegrin domains.
This article has been cited by other articles:
![]() |
P. Zigrino, J. Steiger, J. W. Fox, S. Loffek, A. Schild, R. Nischt, and C. Mauch Role of ADAM-9 Disintegrin-Cysteine-rich Domains in Human Keratinocyte Migration J. Biol. Chem., October 19, 2007; 282(42): 30785 - 30793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Franovic, I. Robert, K. Smith, G. Kurban, A. Pause, L. Gunaratnam, and S. Lee Multiple Acquired Renal Carcinoma Tumor Capabilities Abolished upon Silencing of ADAM17 Cancer Res., August 15, 2006; 66(16): 8083 - 8090. [Abstract] [Full Text] [PDF] |
||||